COVIDIEN LP for COVIDIEN LP
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2012 | $610,000 | Replaced |
| 1st Quarter - Amendment | Oct 19, 2012 | $700,000 | Replaced |
| 1st Quarter - Amendment | Apr 17, 2013 | $720,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S.23/H.R.1249: America Invents Act (all provisions).
Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WHITNEY GARDINER | — |
| JOHN CHRISTOPHER KALAVRITINOS | — |
| TIMOTHY MCBRIDE | — |
Taxation/Internal Revenue Code TAX
International tax on foreign direct investment generally; Corporate Tax Reform generally; S.1346: Stop Tax Haven Abuse Act (all provisions); H.R. 62: International Tax Competitiveness Act of 2011 (all provisions).
Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WHITNEY GARDINER | — |
| TIMOTHY MCBRIDE | — |
Trade (domestic/foreign) TRD
Free Trade Agreement; HR 3078: United State Columbia Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement); HR 3079: United States Panama Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement) HR 3080: United States - Korea Free Trade Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement)
Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WHITNEY GARDINER | — |
| TIMOTHY MCBRIDE | — |
Pharmacy PHA
Issues involving controlled substance and pain and addiction drugs generally; H.R. 2119: Ryan Creedon Act of 2011; Issues related to acetaminophen
Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WHITNEY GARDINER | — |
| JOHN CHRISTOPHER KALAVRITINOS | — |
| TIMOTHY MCBRIDE | — |
Health Issues HCR
General issues related to FDA device approval process; issues related to Patient Protection and Affordable Care Act Implementation (Accountable Care Organization, Medical Device Tax); S.17/S.262/H.R.436/H.R.488/H.R.734: Medical Device Access and Innovation Protection Act (all provisions); HEU/LEU related issues for Nuclear Medicine. S.99: American Medical Isotopes Production Act (all provisions). H.R. 3209: Premarket Predictability Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3203: Novel Device Regulatory Relief Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3230: Keeping America Competitive Through Harmonization Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3205: FDA Renewing Efficiency from Outside Review Management Act. (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3211: Humanitarian Device Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3208: Patients Come First Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3206: Cultivating Scientific Experts to Foster Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3214: Food and Drug Administration Mission Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3204: Guidance Accountability and Transparency Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1700: The Medical Device Regulatory Improvement Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1865: The Patient Access to Medical Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1943: Novel Device Regulatory Relief Act of 2011(All provisions related to the FDA and the regulation of medical devices generally); S. 1972: A bill to amend the Food and Drug Administrations mission (All provisions related to the FDA and the regulation of medical devices generally); S. 1995: A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes (All provisions related to the FDA and the regulation of medical devices generally)
Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WHITNEY GARDINER | — |
| JOHN CHRISTOPHER KALAVRITINOS | — |
| TIMOTHY MCBRIDE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.